Genetic determinants of response to fibroblast growth factor receptor inhibitors in solid tumours

被引：3
|
作者：
Leroy, Laura [1 ,2 ]
Cousin, Sophie [2 ]
Italiano, Antoine [1 ,2 ]
机构：
[1] Univ Bordeaux, Bordeaux, France
[2] Inst Bergonie, Early Phase Trials Unit, Bordeaux, France
来源：
EUROPEAN JOURNAL OF CANCER | 2017年 / 81卷
关键词：
FGFR AMPLIFIED TUMORS; PATIENTS PTS; PHASE-II; AZD4547; CANCER; CHOLANGIOCARCINOMA; MULTICENTER; RESISTANCE; BGJ398;
D O I：
10.1016/j.ejca.2017.04.011
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：102 / 105
页数：4
相关论文
共 50 条
  • [31] Fibroblast growth factor receptor (FGFR) inhibitors: A review of a novel therapeutic class
    Weaver, April
    Bossaer, John B.
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2021, 27 (03) : 702 - 710
  • [32] Structures of the tyrosine kinase domain of fibroblast growth factor receptor in complex with inhibitors
    Mohammadi, M
    McMahon, G
    Sun, L
    Tang, C
    Hirth, P
    Yeh, BK
    Hubbard, SR
    Schlessinger, J
    SCIENCE, 1997, 276 (5314) : 955 - 960
  • [33] Fibroblast growth factor receptor 4 increases epidermal growth factor receptor (EGFR) signaling by inducing amphiregulin expression and attenuates response to EGFR inhibitors in colon cancer
    Hong, Chang-Soo
    Sun, Eun-Gene
    Choi, Ji-Na
    Kim, Dae-Hwan
    Kim, Jo-Heon
    Ryu, Kyung-Hyun
    Shim, Hyun-Jeong
    Hwang, Jun-Eul
    Bae, Woo-Kyun
    Kim, Hyeong-Rok
    Kim, Kyung Keun
    Jung, Chaeyong
    Chung, Ik-Joo
    Cho, Sang-Hee
    CANCER SCIENCE, 2020, 111 (09) : 3268 - 3278
  • [34] Genetic loci that control the angiogenic response to basic fibroblast growth factor
    Rogers, MS
    Rohan, RM
    Birsner, AE
    D'Amato, RJ
    FASEB JOURNAL, 2004, 18 (10): : 1050 - 1059
  • [35] Activation of fibroblast growth factor receptor 3 and oncogene-induced senescence in skin tumours
    Hida, Y.
    Kubo, Y.
    Arase, S.
    BRITISH JOURNAL OF DERMATOLOGY, 2009, 160 (06) : 1258 - 1263
  • [36] Expression of fibroblast growth factor receptor 1 correlates inversely with the efficacy of single-agent fibroblast growth factor receptor-specific inhibitors in pancreatic cancer
    Lin, Qingxiang
    Serratore, Andrea
    Perri, Jonathan
    Chaudhuri, Tista Roy
    Qu, Jun
    Ma, Wen Wee
    Kandel, Eugene
    Straubinger, Robert M.
    BRITISH JOURNAL OF PHARMACOLOGY, 2024, 181 (09) : 1383 - 1403
  • [37] Small molecule inhibitors of the platelet-derived growth factor receptor, the fibroblast growth factor receptor, and Src family tyrosine kinases
    Showalter, HDH
    Kraker, AJ
    PHARMACOLOGY & THERAPEUTICS, 1997, 76 (1-3) : 55 - 71
  • [38] Biomarkers to predict response to epidermal growth factor receptor inhibitors
    Haas-Koogan, DA
    Prados, MD
    Lamborn, KR
    Tihan, T
    Berger, MS
    Stokoe, D
    CELL CYCLE, 2005, 4 (10) : 1369 - 1372
  • [39] Epidermal Growth Factor Receptor Inhibitors and Other Tyrosine Kinase Inhibitors for Solid Tumors
    Ruiz-Camps, Isabel
    Aguilar-Company, Juan
    INFECTIOUS DISEASE CLINICS OF NORTH AMERICA, 2020, 34 (02) : 257 - +
  • [40] An epidermal growth factor receptor intron 1 polymorphism mediates response to epidermal growth factor receptor inhibitors
    Amador, ML
    Oppenheimer, D
    Perea, S
    Maitra, A
    Cusati, G
    Iacobuzio-Donahue, C
    Baker, SD
    Ashfaq, R
    Takimoto, C
    Forastiere, A
    Hidalgo, M
    CANCER RESEARCH, 2004, 64 (24) : 9139 - 9143
12345